Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2005
12/28/2005EP1011717B1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0991658B1 Dolastatin 15 derivatives
12/28/2005EP0971959B1 Humanized antibodies and methods for forming humanized antibodies
12/28/2005EP0940467B1 Promoters for swine complement inhibitors
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0920534B1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) hnf-1alpha, hnf-1beta and hnf-4alpha
12/28/2005EP0920448B1 Truncated glial cell line-derived neurotrophic factor
12/28/2005EP0879281B1 Methods for transforming dendritic cells and activating t cells
12/28/2005EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors
12/28/2005EP0859840B1 Biologically active eph family ligands
12/28/2005EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides
12/28/2005EP0797676B1 Recombinant adenoviral vector and methods of use
12/28/2005EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
12/28/2005EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity
12/28/2005EP0682529B2 Antibody for the treatment of insulin dependent diabetes
12/28/2005EP0672159B1 Homologous sequence targeting in eukaryotic cells
12/28/2005EP0652964B1 K. lactis transaldolase gene promoter and use thereof
12/28/2005EP0646175B1 Recombinant pseudomonas exotoxin with increased activity
12/28/2005CN1714153A Recombinant protein variants
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714100A Antigen peptides
12/28/2005CN1713920A Modified transferrin fusion proteins
12/28/2005CN1713919A Novel use of erythropoietin in heart diseases
12/28/2005CN1713918A Muscle building preparation
12/28/2005CN1713861A Vascularization enhanced graft constructs
12/28/2005CN1712415A Connexin transduction structural domain and bioactive protein of auxiliary protein, its production and use
12/28/2005CN1712067A Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer
12/28/2005CN1712066A Use of full lenth human PTH
12/28/2005CN1712065A Production of fowl leukocyte interferon
12/28/2005CN1712064A Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation
12/28/2005CN1233839C Productive method of recombinant human liver regenerated enhanced factor
12/28/2005CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
12/28/2005CN1233658C Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof
12/28/2005CN1233656C Unsaturated fatty acid modified insulin and preparing method thereof
12/28/2005CN1233420C Method for preparation of polymeric micelle via separation of block copolymer
12/28/2005CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/28/2005CN1233416C Compound pepsin powder for treating child dyspepsia and its preparation method
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233414C Muscular amino acid and peptide nucleoside powder injection and its preparation method
12/28/2005CN1233413C Nano particle feeding system for oral use
12/28/2005CN1233412C Preparation of polygelatine peptide injection
12/28/2005CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis
12/28/2005CN1233230C Method for preserving a hemoglobin blood substitute
12/27/2005US6979730 Nucleic acids encoding prostate stem cell antigen
12/27/2005US6979727 Polypeptide for use in the treatment and prevention of viral diseases
12/27/2005US6979726 Immunoconjugates
12/27/2005US6979724 Nucleotide sequences coding polypeptide for use in the treatment tumors, nervous system and cardiovascular disorders
12/27/2005US6979723 Preparing preferential glycoprotein; obtain chemical intermediate, expose to vancomycin, an amine and formaldehyde, recover glycopeptide
12/27/2005US6979697 Regulation of substrate activity
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979682 Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
12/27/2005US6979677 Inhibition of vascular smooth muscle cell proliferation
12/27/2005US6979674 A sustained-release pharmaceutical formulation containing a granulocyte-colony stimulating factor (G-CSF), polyol:oil and a thickener
12/27/2005US6979673 Method and compositions for modulating somatolactogenic functions
12/27/2005US6979672 Cyclosporin-based pharmaceutical compositions
12/27/2005US6979671 Preventing an inflammatory or immune disorder in a subject while eliminating or reducing the toxicity associated with the administration of cyclosporin A, comprising systemically administering to said subject a pharmaceutical composition and
12/27/2005US6979670 providing a graft from a suitable donor, cultured epidermal cells, acellular dermal matrix, cellular matrix, skin, mucosa, applying a prophylactically active enamel to a non-mineralized tissue recipient lesion, placing the graft on the lesion
12/27/2005US6979572 a modified tertiapin peptide containing a stable tertiapin derivative wherein the methionine residue in position 13 of tertiapin is replaced by glutamine. controls insulin secretion, cardiac rhythm, electrical conduction
12/27/2005US6979563 Attenuation of tumor growth, metastasis and angiogenesis
12/27/2005US6979559 Polyvalent cation-sensing receptor in atlantic salmon
12/27/2005US6979558 Polyvalent cation-sensing receptor in Atlantic salmon
12/27/2005US6979555 Hyaluronan receptor for endocytosis
12/27/2005US6979554 polypeptide has an affinity for a phospholipid selected from a phosphatidylserine, a phosphatidylethanolamine, a phosphatidylinositol, a phosphatidic acid, and a cardiolipin
12/27/2005US6979549 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
12/27/2005US6979546 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979538 Directed evolution of novel binding proteins
12/27/2005US6979535 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005US6979445 Method for treating von willebrand's disease
12/27/2005US6979443 Chemokine α-6
12/27/2005US6979442 granulocyte colony stimulating factor (G-CSF) and a stabilizing buffer; sustained release; for preventing or treating infections in mammals
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2188887C Nutritional coffee composition
12/27/2005CA2166001C Stable solid formulation of enalapril salt and process for preparation thereof
12/22/2005WO2005121801A2 Diagnosis of anemia and optimizing treatment for organ repair
12/22/2005WO2005121344A1 Proteins with attached short peptide of acidic amino acids
12/22/2005WO2005121343A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005WO2005121329A2 Method for ameliorating an inflammatory skin condition
12/22/2005WO2005121328A2 Method for ameliorating an inflammatory skin condition
12/22/2005WO2005121320A1 Autonomouos replication promoter for stem cells
12/22/2005WO2005121176A1 Angiogenesis-inhibiting chimeric protein and the use
12/22/2005WO2005121172A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci
12/22/2005WO2005121169A2 Apoptosis-inducing polypeptides
12/22/2005WO2005121167A1 Monocyte locomotion inhibitory factor
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005120588A2 Peptides delivered to cell nuclei
12/22/2005WO2005120581A2 Gene therapy for neurometabolic disorders
12/22/2005WO2005120564A2 Vaccine compositions and methods
12/22/2005WO2005120562A2 Structure-based receptor mimics targeted against bacterial superantigen toxins
12/22/2005WO2005120557A2 Inhibition of macrophage-stimulating protein receptor (ron)
12/22/2005WO2005120556A1 Human lysozyme medicine, its manufacturing method and application thereof
12/22/2005WO2005120555A1 Use of human lysozyme in preparation of medicine for treating acne
12/22/2005WO2005120554A1 Cosmetic preparations containing pth fragments
12/22/2005WO2005120553A2 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues
1 ... 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 ... 3163